MEI Pharma (NASDAQ: MEIP) recently received a number of ratings updates from brokerages and research firms: 11/25/2023 – MEI Pharma is now covered by analysts at StockNews.com. They set a “hold” rating on the stock. 11/17/2023 – MEI Pharma was upgraded by analysts at TheStreet from a “d-” rating to a “c-” rating. 11/17/2023 – […]